Exagen (XGN) Other financing activities (2020 - 2025)

Exagen (XGN) reported Other financing activities of $199000.0 for Q3 2025, down 67.11% quarter-over-quarter from $605000.0 in Q2 2025.

Exagen (XGN) Other financing activities (2020 - 2025) Analysis & Trends

Exagen has reported Other financing activities for 3 years, with the latest figure at $199000.0 in Q3 2025.

For the quarter ending Q3 2025, Other financing activities changed N/A year-over-year to $199000.0; the trailing twelve-month figure through Mar 2026 stood at $804000.0 (up 1136.92% YoY), and the FY2025 full-year result was $869000.0, changed N/A from the prior year.
Other financing activities for Q3 2025 stood at $199000.0, down from $605000.0 in the prior quarter.
The five-year high for Other financing activities was $4.2 million in Q1 2021, with the low at $65000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn
10	Exagen	102.82 Mn	81.30 Mn	10.21 Mn

Download Data